Sameday Health Launches Monkeypox Testing in California

In Sameday Health’s eyes, healthcare is not simply a service but an all-encompassing experience. To deliver client-centered healthcare, we combine a human approach with cutting-edge technology. Whether in one of our clinics or at home, we offer high-quality, individualized care wherever you are.

Sameday Health is committed to providing our clients with hope and assistance. The ability of the blossoming flower to thrive in even the most difficult situations impressed us. Since our first clinic opened in Venice, California, at the height of the COVID-19 pandemic, the Sameday team has been devoted to bridging gaps in the healthcare system from diagnosis to wellness to treatment.

Sameday Health attends to customers whenever and wherever is most convenient. Something usually happens on the same day at home. Monkeypox testing is available at several California clinics, including Venice, Manhattan Beach, and Downtown Los Angeles. Sameday Health, prominent testing and wellness provider, plans to open clinics around the country shortly. The announcement follows the World Health Organization’s and the US government’s separate designations of monkeypox as a health crisis and an international health emergency. In contrast to collecting samples from lesions, Sameday Health’s monkeypox testing services use laboratory-developed saliva tests, which are less intrusive, painless, and efficient. For sites participating in Sameday Health, self-pay is available for $125. Within 48 hours, clients should get test results.

Felix Huettenbach, Sameday’s founder and CEO, feels that no amount of information can stop an outbreak without cheap testing choices that eliminate obstacles to care. When new threats to public health are uncovered, Sameday Health’s infrastructure and diagnostic services help to ensure the community’s well-being. According to Patrick Emad, Vice President of Clinics at Sameday, the capacity to gather information is critical for safeguarding public health. They boost community health and ensure that persons from disadvantaged backgrounds have access to critical medical services during this crisis by providing a rapid and efficient quasi-substitute to monkeypox testing.